Insider · CIK 0002073994
Steve Lawrence Meyers
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing -, latest -.
In brief
Steve Lawrence Meyers files SEC Form 4 as officer at OCUL (OCULAR THERAPEUTIX, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steve Lawrence Meyers has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 12, 2026 | OCUL OCULAR THERAPEUTIX, INC. | 6,864 0.00% of outstanding | $62k | Feb 12, 2026 | $66k |
| Feb 4, 2026 | OCUL OCULAR THERAPEUTIX, INC. | 4,408 0.00% of outstanding | $38k | Feb 4, 2026 | $28k |
| Feb 2, 2026 | OCUL OCULAR THERAPEUTIX, INC. | 3,052 0.00% of outstanding | $28k | Feb 2, 2026 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +64,900 | $0.00 | $0 | 217,628 | Jan 6, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +197,650 | $0.00 | $0 | 197,650 | Jan 6, 2026 |
Questions about Steve Lawrence Meyers
Answered from the filings on this page, as of the latest one.
Is Steve Lawrence Meyers buying or selling?
Steve Lawrence Meyers has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steve Lawrence Meyers's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steve Lawrence Meyers has 0.
Where does Steve Lawrence Meyers file Form 4?
Steve Lawrence Meyers has filed Form 4 at OCUL (OCULAR THERAPEUTIX, INC) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.